Back To Schedule
Tuesday, November 27 • 1:30pm - 3:00pm
B-22 - Closing the Gap: Screening for Mental Illness, Substance Use Disorders. and Neurocognitive Impairment (CE)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Mental illness and substance use disorders are common co-morbidities among people with HIV infection. These conditions are under-diagnosed and under-treated despite extensive evidence that they are associated with HIV transmission risk, failure to initiate and adhere to treatment, slower viral suppression, faster virilogic failure, and increased morbidity and mortality. HIV-related neurocognitive disorders are also common (even among people on effective antiretroviral treatment) and can interfere with treatment through forgetfulness, the most common reason for nonadherence to medication. This workshop seeks to encourage the use of screening tools to identify important and neglected co-morbidities that undermine HIV care and treatment. All three goals of the National HIV/AIDS Strategy are addressed by promoting treatment as prevention, optimizing health outcomes and addressing well-known health disparities in the detection and treatment of mental, substance use and neuropsychiatric disorders.

Learning Objectives:

  • Participants will be better able to identify useful mental health/substance use/neurocognitive screening tools, know how to access them on line in multiple languages, and obtain companion scoring sheets.
  • Participants will be better able to identify mental health/substance use/neurocognitive co-morbidities in their patients and/or programs through increased comfort with and knowledge of how to administer and score these screening instruments.
  • Participants will be better able to decide which of these co-morbidities they/their programs can treat and which require referral to other providers.


Andrea Knox

AETC Project Officer, HRSA, HIV/AIDS Bureau


Francine Cournos,M.D.

Principal Investigator, NY/NJ AETC
Francine Cournos, M.D. is Professor of Clinical Psychiatry (in Epidemiology) at the Mailman School of Public Health at Columbia University and Principal Investigator of the New York/New Jersey AIDS Education and Training Center. She has worked at the interface of HIV and mental illness... Read More →

Antoine Douaihy,M.D.

Co-investigator, Pennsylvania Mid-Atlantic AIDS Education and Training Center
Antoine Douaihy, MD, is currently Associate Professor of psychiatry at the University Of Pittsburgh School Of Medicine (UPSOM). He is the Medical Director of Addiction Medicine Services (AMS) at Western Psychiatric Institute and Clinic. Dr. Douaihy is the Medical Director of Addiction... Read More →

Marshall Forstein,M.D.

Chair, American Psychiatric Association Steering Committee on HIV Education and Training
Marshall Forstein, MD is the Director of Psychiatry Residency Training at The Cambridge Health Alliance, and Associate Professor of Psychiatry at Harvard Medical School. He has been involved clinically and educationally in the HIV epidemic since the very beginning in 1981 and is currently... Read More →

Tuesday November 27, 2012 1:30pm - 3:00pm EST
Wilson C

Attendees (0)